ATOSSA THERAPEUTICS INC's ticker is ATOS and the CUSIP is 04962H506. A total of 51 filers reported holding ATOSSA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $35,363 | +1768050.0% | 29,717 | +2971600.0% | 0.00% | – |
Q1 2024 | $2 | -100.0% | 1 | -100.0% | 0.00% | – |
Q4 2023 | $9,459 | -3.0% | 10,749 | -18.8% | 0.00% | – |
Q3 2023 | $9,753 | -53.9% | 13,233 | -21.2% | 0.00% | -100.0% |
Q2 2023 | $21,148 | +264250.0% | 16,784 | +61.4% | 0.00% | – |
Q1 2023 | $8 | +300.0% | 10,400 | +196.2% | 0.00% | – |
Q4 2022 | $2 | – | 3,511 | +8065.1% | 0.00% | – |
Q3 2022 | $0 | -100.0% | 43 | -96.8% | 0.00% | – |
Q2 2022 | $1,000 | -96.9% | 1,351 | -94.7% | 0.00% | – |
Q1 2022 | $32,000 | -11.1% | 25,391 | +13.6% | 0.00% | -100.0% |
Q4 2021 | $36,000 | +50.0% | 22,360 | +195.6% | 0.00% | 0.0% |
Q3 2021 | $24,000 | -20.0% | 7,564 | +58.0% | 0.00% | 0.0% |
Q2 2021 | $30,000 | +900.0% | 4,787 | +292.4% | 0.00% | – |
Q3 2020 | $3,000 | -50.0% | 1,220 | -27.2% | 0.00% | – |
Q2 2020 | $6,000 | 0.0% | 1,676 | -25.5% | 0.00% | – |
Q2 2019 | $6,000 | – | 2,250 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 524,805 | $572,000 | 0.39% |
Laurion Capital Management LP | 2,225,800 | $2,426,000 | 0.04% |
Ergoteles LLC | 514,600 | $561,000 | 0.02% |
Pinz Capital Management, LP | 17,900 | $20,000 | 0.01% |
Alpine Global Management, LLC | 37,089 | $40,000 | 0.01% |
Game Plan Financial Advisors, LLC | 10,000 | $11,000 | 0.01% |
Spire Wealth Management | 100,300 | $109,000 | 0.00% |
Renaissance Technologies | 1,989,995 | $2,169,000 | 0.00% |
D. E. Shaw & Co., Inc. | 2,279,636 | $2,485,000 | 0.00% |
Y-Intercept (Hong Kong) Ltd | 16,912 | $18,000 | 0.00% |